BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 17157157)

  • 1. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
    Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
    Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG).
    Wang JC; Hemavathy K; Charles W; Zhang H; Dua PK; Novetsky AD; Chang T; Wong C; Jabara M
    Exp Hematol; 2004 Oct; 32(10):905-10. PubMed ID: 15504545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of melanoma-associated growth factors in keratinocytes and fibroblasts by ultraviolet A and ultraviolet B radiation.
    Brenner M; Degitz K; Besch R; Berking C
    Br J Dermatol; 2005 Oct; 153(4):733-9. PubMed ID: 16181453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of TGF beta1RII in agnogenic myeloid metaplasia is not due to mutation or methylation.
    Hemavathy KC; Chang TH; Zhang H; Charles W; Goldberg A; Aithal S; Novetsky AD; Wang JC
    Leuk Res; 2006 Jan; 30(1):47-53. PubMed ID: 16054691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
    Shehata M; Schwarzmeier JD; Hilgarth M; Hubmann R; Duechler M; Gisslinger H
    J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
    Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
    Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions.
    Borrelli V; di Marzo L; Sapienza P; Colasanti M; Moroni E; Cavallaro A
    Surgery; 2006 Sep; 140(3):454-63. PubMed ID: 16934609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factor production by a human megakaryocytic tumor cell line.
    Witte DP; Stambrook PJ; Feliciano E; Jones CL; Lieberman MA
    J Cell Physiol; 1988 Oct; 137(1):86-94. PubMed ID: 3049629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines.
    Shimabukuro T; Ohmoto Y; Naito K
    J Urol; 2003 May; 169(5):1865-9. PubMed ID: 12686863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for TGF-beta1, FGF-2 and PDGF-AA in a myelination of CNS aggregate cultures enriched with macrophages.
    Diemel LT; Jackson SJ; Cuzner ML
    J Neurosci Res; 2003 Dec; 74(6):858-67. PubMed ID: 14648590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
    Michiels JJ; Thiele J
    Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines.
    Catani L; Amabile M; Luatti S; Valdrè L; Vianelli N; Martinelli G; Tura S
    Stem Cells; 2001; 19(4):339-47. PubMed ID: 11463954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and synthesis of fibroblast growth factor-9 in human gammadelta T-lymphocytes. Response to isopentenyl pyrophosphate and TGF-beta1/IL-15.
    Workalemahu G; Foerster M; Kroegel C
    J Leukoc Biol; 2004 Apr; 75(4):657-63. PubMed ID: 14704367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heparin on production of transforming growth factor (TGF)-beta1 and TGF-beta1 mRNA expression by human normal skin and hyperplastic scar fibroblasts.
    Fan SQ; Cai JL; Qin LY; Wang ZH; Liu ZZ; Sun ML
    Ann Plast Surg; 2008 Mar; 60(3):299-305. PubMed ID: 18443513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.
    Hrycek A; Kusmierz D; Dybała T; Swiatkowska L
    Autoimmunity; 2007 Feb; 40(1):23-30. PubMed ID: 17364494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wound repair by bone marrow stromal cells through growth factor production.
    Liu Y; Dulchavsky DS; Gao X; Kwon D; Chopp M; Dulchavsky S; Gautam SC
    J Surg Res; 2006 Dec; 136(2):336-41. PubMed ID: 17045612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
    Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
    Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of aldosterone on synthesis of fibronectin and expression of transforming growth factor-beta1 mRNA in cultured rat mesangial cells].
    Li XD; Chen XW; Tang DS; Liang D; Liu HF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):140-2. PubMed ID: 17286908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
    Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
    Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.